A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors Meeting Abstract
| Authors: | Jhaveri, K.; Juric, D.; Saura, C.; Cervantes, A.; Melnyk, A.; Patel, M. R.; Oliveira, M.; Gambardella, V.; Ribrag, V.; Ma, C. X.; Aljumaily, R.; Bedard, P. L.; Sachdev, J. C.; Bond, J.; Jones, S.; Wilson, T. R.; Wei, M. C.; Baselga, J. |
| Abstract Title: | A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA-mutated locally advanced or metastatic solid tumors |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900043 |
| DOI: | 10.1158/1538-7445.Am2018-ct046 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT046 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work